Amanote Research
Register
Sign In
OA10.05 an Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients With Uncommon EGFR Mutation(KCSG-Lu15-09)
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.291
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
J.H. Cho
J. Sun
S. Lee
J.S. Ahn
K. Park
K.U. Park
E.J. Kang
Y.H. Choi
K.H. Kim
H.J.A. An
H.W. Lee
M. Ahn
Publisher
Elsevier BV
Related search
Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy Within a Natural History Study
PLoS ONE
Multidisciplinary
Duchenne Muscular Dystrophy
Physiotherapy
Physical Therapy
Sports Therapy
Rehabilitation
Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Methods in Molecular Biology
Genetics
Molecular Biology
Duchenne Muscular Dystrophy
The Natural History of the Patients With Duchenne Muscular Dystrophy in Taiwan: A Medical Center Experience
Pediatrics and Neonatology
Child Health
Pediatrics
Perinatology
Emerging Drugs for Duchenne Muscular Dystrophy
Expert Opinion on Emerging Drugs
Pharmacology
Gene Therapy for Duchenne Muscular Dystrophy
Archives of Neurology
Severe Metabolic Acidosis in Adult Patients With Duchenne Muscular Dystrophy
Respiration
Pulmonary
Respiratory Medicine
150. Ex Vivo Gene Therapy of Duchenne Muscular Dystrophy Using iPSCs From Duchenne Muscular Dystrophy Patients
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
